Benzinga | Mar 26, 2021 08:32AM EDT

Benchmark Initiates Coverage On Ultralife with Buy Rating, Announces Price Target of $12

Benchmark analyst Josh Sullivan initiates coverage on Ultralife (NASDAQ:ULBI) with a Buy rating and announces Price Target of $12.